Bio-Techne Corporation (NASDAQ:TECH) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Fourth Quarter of Fiscal Year 2023.
Bio-Techne Corp (TECH)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
Should You Hold Bio-Techne Corp. (TECH)?
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” first-quarter 2023 investor letter. A copy of the same can be downloaded here.
Bio-Techne Corporation (NASDAQ:TECH) Q3 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Bio-Techne Corp Third Quarter Fiscal 2023 Earnings Call. All participants will be in a listen-only mode. Please note today’s event is being recorded.
Here’s Why Bio-Techne Corporation (TECH) Declined in Q1
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Bio-Techne Corporation (NASDAQ:TECH) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2023.
Do You Think Bio-Techne Corporation (TECH) Has a Positive Long-Term Trend?
Jackson Square Partners, an investment management firm, released its “SMID-Cap Growth” Q3 2022 investor letter. A copy of the same can be downloaded here.
Should You Invest in Bio-Techne Corporation (TECH)?
Conestoga Capital Advisors, an asset management company, released its “Conestoga Mid Cap Growth Fund” third-quarter investor letter. A copy of the same can be downloaded here.
Should You Invest in Bio-Techne Corporation (TECH)?
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Can Bio-Techne Corporation (TECH) Still Bounce Back?
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Baron Funds: "Bio-Techne (TECH) is a Stable Business"
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2022 investor letter – a copy of which can be downloaded here.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
